Lowering FIT Positivity Thresholds Improves Sensitivity, Specificity
By Elana Gotkine HealthDay Reporter
WEDNESDAY, June 5, 2024 -- Lowering the fecal immunochemical test (FIT) positive threshold yields levels of sensitivity and specificity that are comparable to those reported for multitarget stool RNA (mt-sRNA) testing without the additional testing, according to a research letter published online June 1 in the Journal of the American Medical Association.
Tobias Niedermaier, Ph.D., from the German Cancer Research Center in Heidelberg, and colleagues examined whether lowering the FIT positivity threshold could achieve levels of sensitivity and specificity comparable to mt-sRNA testing, which incorporates a commercially available FIT, concentration of eight RNA transcripts, and participant-reported smoking status, without additional stool testing and smoking assessment. The sensitivities of FIT for detecting colorectal cancer (CRC) or advanced adenoma and specificity for absence of advanced neoplasia were ascertained for FIT in the BLITZ study after lowering the positivity threshold to 8.8 µg/g, which yielded the same positivity rate as reported for the mt-sRNA test in the CRC-PREVENT study (17 percent). A total of 7,607 participants were included in the analyses.
The researchers found that lowering the FIT positivity threshold achieved similar sensitivities for CRC (94.9 versus 94.4 percent) and for advanced adenoma (44.7 versus 45.9 percent). Specificities were also similar (86.9 versus 85.5 percent).
"Future comparisons of novel stool-based screening tests with FITs should incorporate comparisons of sensitivities at the same positivity rate or specificity," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2024
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.